598
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of selective-serotonin reuptake inhibitors and anti-androgens to manage sexual compulsivity in individuals serving a custodial sentence for a sexual offence

ORCID Icon, , , , , , , , ORCID Icon, , & show all
Pages 425-460 | Received 19 Dec 2022, Accepted 07 Feb 2024, Published online: 16 Apr 2024

References

  • Akerman, G. (2008). The development of a fantasy modification programme for a prison-based therapeutic community. International Journal of Therapeutic Communities, 29(2), 180–188.
  • Balon, R., & Briken, P. (2021). Compulsive sexual behavior disorder: Understanding, assessment, and treatment. American Psychiatric Pub.
  • Bancroft, J. (2008). Sexual behavior that is “out of control”: A theoretical conceptual approach. Psychiatric Clinics of North America, 31(4), 593–601. https://doi.org/10.1016/j.psc.2008.06.009
  • Barros, S., Oliveira, C., Araújo, E., Moreira, D., Almeida, F., & Santos, A. (2022). Community intervention programs for sex offenders: A systematic review. Frontiers in Psychiatry, 13, 949899. https://doi.org/10.3389/fpsyt.2022.949899
  • Beech, A. R., & Mitchell, I. J. (2005). A neurobiological perspective on attachment problems in sexual offenders and the role of selective serotonin re-uptake inhibitors in the treatment of such problems. Clinical Psychology Review, 25(2), 153–182. https://doi.org/10.1016/j.cpr.2004.10.002
  • Björkqvist, K. (2001). Social defeat as a stressor in humans. Physiology & Behavior, 73(3), 435–442. https://doi.org/10.1016/S0031-9384(01)00490-5
  • Blanchard, G. (1990). Differential diagnosis of sex offenders: Distinguishing characteristics of the sex addict. American Journal of Preventive Psychiatry and Neurology, 2(3), 45–47.
  • Bonta, J., & Andrews, D. A. (2007). Risk-need-responsivity model for offender assessment and rehabilitation. Rehabilitation, 6(1), 1–22.
  • Bradford, J. M. (2001). The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour. The Canadian Journal of Psychiatry, 46(1), 26–34. https://doi.org/10.1177/070674370104600104
  • Bradford, J. M. W. (2000). The treatment of sexual deviation using a pharmacological approach. Journal of Sex Research, 37(3), 248–257. https://doi.org/10.1080/00224490009552045
  • Bradford, J. M., & Pawlak, A. (1993). Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Archives of Sexual Behavior, 22(5), 383–402. https://doi.org/10.1007/BF01542555
  • Briken, P. (2020). An integrated model to assess and treat compulsive sexual behaviour disorder. Nature Reviews Urology, 17(7), 391–406. https://doi.org/10.1038/s41585-020-0343-7
  • Briken, P., Hill, A., & Berner, W. (2003). Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: A systematic review. The Journal of Clinical Psychiatry, 64(8), 890–897. https://doi.org/10.4088/JCP.v64n0806
  • Brody, S., & Costa, R. M. (2009). Satisfaction (sexual, life, relationship, and mental health) is associated directly with penile–vaginal intercourse, but inversely with other sexual behavior frequencies. The Journal of Sexual Medicine, 6(7), 1947–1954. https://doi.org/10.1111/j.1743-6109.2009.01303.x
  • Brotherton, J. (1974). Effect of oral cyproterone acetate on urinary and serum FSH and LH levels in adult males being treated for hypersexuality. Reproduction, 36(1), 177–187. https://doi.org/10.1530/jrf.0.0360177
  • Burns, L., & Hull, J. (2014). Unlicensed and Off-Label Medication. Oxford University Hospitals NHS Foundation Trust. https://www.ouh.nhs.uk/patient-guide/leaflets/files/12048Punlicensed.pdf
  • Carnes, P. (1991). Don’t call it love: Recovering from sexual addiction. Bantam.
  • Carnes, P. (1994). Contrary to love: Helping the sexual addict. Hazelden Publishing.
  • Carnes, P. (2001). Out of the shadows: Understanding sexual addiction. Hazelden Publishing.
  • Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016). The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: A critical review of the literature. Psychotherapy and Psychosomatics, 85(5), 270–288. https://doi.org/10.1159/000447034
  • Cascade, E., Kalali, A. H., & Kennedy, S. H. (2009). Real-world data on SSRI antidepressant side effects. Psychiatry (Edgmont), 6(2), 16.
  • Colstrup, H., Larsen, E. D., Mollerup, S., Tarp, H., Soelberg, J., & Rosthøj, S. (2020). Long-term follow-up of 60 incarcerated male sexual offenders pharmacologically castrated with a combination of GnRH agonist and cyproterone acetate. The Journal of Forensic Psychiatry & Psychology, 31(2), 241–254. https://doi.org/10.1080/14789949.2020.1711957
  • Darjee, R., & Quinn, A. (2020). Pharmacological treatment of sexual offenders. In J. Proulx, F. Cortoni, L. A. Craig, & E. J. Letourneau (Eds.), The Wiley handbook of what works with sexual offenders: Contemporary perspectives in theory, assessment, treatment, and prevention (pp. 217–245). John Wiley & Sons Ltd. https://doi.org/10.1002/9781119439325.ch13.
  • Dodge, B., Reece, M., Herbenick, D., Fisher, C., Satinsky, S., & Stupiansky, N. (2008). Relations between sexually transmitted infection diagnosis and sexual compulsivity in a community-based sample of men who have sex with men. Sexually Transmitted Infections, 84(4), 324–327. https://doi.org/10.1136/sti.2007.028696
  • Engel, J., Veit, M., Sinke, C., Heitland, I., Kneer, J., Hillemacher, T., Hartmann, U., & Kruger, T. H. (2019). Same same but different: A clinical characterization of men with hypersexual disorder in the sex@ brain study. Journal of Clinical Medicine, 8(2), 157. https://doi.org/10.3390/jcm8020157
  • English, K. (1998). The containment approach: An aggressive strategy for the community management of adult sex offenders. Psychology, Public Policy, and Law, 4(1–2), 218. https://doi.org/10.1037/1076-8971.4.1-2.218
  • Eriksson, T., & Eriksson, M. (1998). Irradiation therapy prevents gynecomastia in sex offenders treated with antiandrogens. The Journal of Clinical Psychiatry, 59(8), 432–432. https://doi.org/10.4088/JCP.v59n0806e
  • Finkelhor, D. (1984). Child sexual abuse: New theory and research. The Free Press.
  • Finlay, W. M., & Lyons, E. (2002). Acquiescence in interviews with people who have mental retardation. Mental Retardation, 40(1), 14–29. https://doi.org/10.1352/0047-6765(2002)040<0014:AIIWPW>2.0.CO;2
  • Freel, A., & Wakeling, H. (2023). The healthy sex programme an exploration of pre-to-post psychological test change. Ministry of Justice Analytical. https://assets.publishing.service.gov.uk/media/63f4d6f28fa8f56131d0ee8e/healthy-sex-programme.pdf
  • Gallo, A., Abracen, J., Looman, J., Jeglic, E., & Dickey, R. (2019). The use of leuprolide acetate in the management of high-risk sex offenders. Sexual Abuse, 31(8), 930–951. https://doi.org/10.1177/1079063218791176
  • Garcia, F. D., & Thibaut, F. (2010). Sexual addictions. The American Journal of Drug and Alcohol Abuse, 36(5), 254–260. https://doi.org/10.3109/00952990.2010.503823
  • Gelenberg, A. J., & Chesen, C. L. (2000). How fast are antidepressants? The Journal of Clinical Psychiatry, 61(10), 712–721. https://doi.org/10.4088/JCP.v61n1002
  • Gerressu, M., Mercer, C. H., Graham, C. A., Wellings, K., & Johnson, A. M. (2008). Prevalence of masturbation and associated factors in a British national probability survey. Archives of Sexual Behavior, 37, 266–278.
  • Gil, M., Oliva, B., Timoner, J., Maciá, M. A., Bryant, V., & de Abajo, F. J. (2011). Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: Evidence from a population‐based cohort study. British Journal of Clinical Pharmacology, 72(6), 965–968. https://doi.org/10.1111/j.1365-2125.2011.04031.x
  • Gregório Hertz, P., Rettenberger, M., Turner, D., Briken, P., & Eher, R. (2022). Hypersexual disorder and recidivism risk in individuals convicted of sexual offenses. The Journal of Forensic Psychiatry & Psychology, 33(4), 572–591. https://doi.org/10.1080/14789949.2022.2053183
  • Groneman, C. (1994). Nymphomania: The historical construction of female sexuality. Signs: Journal of Women in Culture and Society, 19(2), 337–367. https://doi.org/10.1086/494887
  • Grov, C., Parsons, J. T., & Bimbi, D. S. (2010). Sexual compulsivity and sexual risk in gay and bisexual men. Archives of Sexual Behavior, 39(4), 940–949. https://doi.org/10.1007/s10508-009-9483-9
  • Grubin, D. (2008). Medical models and interventions in sexual deviance. In D. R. Laws & W. T. O’Donohue (Eds.), Sexual Deviance (pp. 594–610). The Guildford Press.
  • Grubin, D. (2018). The pharmacological treatment of sex offenders. In A. R. Beech, A. J. Carter, R. E. Mann, & P. Rotshtein (Eds.), The Wiley Blackwell handbook of forensic neuroscience (pp. 703–723). John Wiley & Sons Ltd. https://doi.org/10.1002/9781118650868.ch27.
  • Grubin, D., Winder, B. & Cass, S.(2021). The use of medication in the treatment of people with sexual convictions. Nota Briefing. https://www.nota.co.uk/wp-content/uploads/2019/01/NOTA-medication-paper-ready-for-publication.pdf
  • Guay, D. R. (2009). Drug treatment of paraphilic and nonparaphilic sexual disorders. Clinical Therapeutics, 31(1), 1–31. https://doi.org/10.1016/j.clinthera.2009.01.009
  • Hall, G. C. N. (1995). Sexual offender recidivism revisited: A meta-analysis of recent treatment studies. Journal of Consulting and Clinical Psychology, 63(5), 802. https://doi.org/10.1037/0022-006X.63.5.802
  • Hallikeri, V. R., Gouda, H. S., Aramani, S. C., Vijaykumar, A. G., & Ajaykumar, T. S. (2010). Masturbation—An overview. Journal of Forensic Medicine and Toxicology, 27(2), 44–47.
  • Hamilton-Giachritsis, C., Hanson, E., Whittle, H., & Beech, A. (2017). “Everyone deserves to feel happy and safe”: A mixed methods study exploring how online and offline child sexual abuse impact young people and how professionals respond to it. NSPCC Publications. https://www.nspcc.org.uk/globalassets/documents/research-reports/impact-online-offline-child-sexual-abuse.pdf.
  • Hanson, R. K., Gordon, A., Harris, A. J., Marques, J. K., Murphy, W., Quinsey, V. L., & Seto, M. C. (2002). First report of the collaborative outcome data project on the effectiveness of psychological treatment for sex offenders. Sexual Abuse: A Journal of Research and Treatment, 14(2), 169–194. https://doi.org/10.1177/107906320201400207
  • Hanson, R. K., & Morton-Bourgon, K. E. (2004). Predictors of sexual recidivism: An updated meta-analysis. (Corrections Research User Report No. 2004–02). Public Safety and Emergency Preparedness Canada.
  • Hanson, R. K., & Morton-Bourgon, K. E. (2005). The characteristics of persistent sexual offenders: A meta-analysis of recidivism studies. Journal of Consulting and Clinical Psychology, 73(6), 1154–1163. https://doi.org/10.1037/0022-006X.73.6.1154
  • Heal, L. W., & Sigelman, C. K. (1995). Response biases in interviews of individuals with limited mental ability. Journal of Intellectual Disability Research, 39(4), 331–340. https://doi.org/10.1111/j.1365-2788.1995.tb00525.x
  • Heinemann, L. A., Will‐Shahab, L., Van Kesteren, P., & Gooren, L. J. (1997). Safety of cyproterone acetate: Report of active surveillance. Pharmacoepidemiology and Drug Safety, 6(3), 169–178. https://doi.org/10.1002/(SICI)1099-1557(199705)6:3<169:AID-PDS263>3.0.CO;2-3
  • Hensley, C., Tewksbury, R., & Wright, J. (2001). Exploring the dynamics of masturbation and consensual same-sex activity within a male maximum security prison. The Journal of Men’s Studies, 10(1), 59–71. https://doi.org/10.3149/jms.1001.59
  • Hill, A., Briken, P., Kraus, C., Strohm, K., & Berner, W. (2003). Differential pharmacological treatment of paraphilias and sex offenders. International Journal of Offender Therapy and Comparative Criminology, 47(4), 407–421. https://doi.org/10.1177/0306624X03253847
  • HMPPS. (2008). Psychiatric assessment for sexual offenders: Interventions group.
  • Hocken, K., Winder, B., & Lievesley, R. (2015). The use of anti-androgen and SSRI medication to treat sexual preoccupation in intellectually disabled sexual offenders: Client characteristics and response to treatment. Presentation to ATSA conference, Montreal, Canada. Association for the Treatment and Prevention of Sexual Abuse.
  • Holden, B., & Gitlesen, J. P. (2004). Psychotropic medication in adults with mental retardation: Prevalence, and prescription practices. Research in Developmental Disabilities, 25(6), 509–521. https://doi.org/10.1016/j.ridd.2004.03.004
  • Hook, J. N., Hook, J. P., Davis, D. E., Worthington, E. L., Jr., & Penberthy, J. K. (2010). Measuring sexual addiction and compulsivity: A critical review of instruments. Journal of Sex & Marital Therapy, 36(3), 227–260. https://doi.org/10.1080/00926231003719673
  • Hu, X. H., Bull, S. A., Hunkeler, E. M., Ming, E., Lee, J. Y., Fireman, B., & Markson, L. E. (2004). Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: Patient report versus physician estimate. The Journal of Clinical Psychiatry, 65(7), 959–965. https://doi.org/10.4088/jcp.v65n0712
  • Hughes, S. D. (2020). Release within confinement: An alternative proposal for managing the masturbation of incarcerated men in US Prisons. Journal of Positive Sexuality, 6(1), 4–23. https://doi.org/10.51681/1.611
  • Huygh, J., Verhaegen, A., Goethals, K., Cosyns, P., De Block, C., & Van Gaal, L. (2015). Prolonged flare-up of testosterone after administration of a gonadotrophin agonist to a sex offender: An under-recognized risk. Criminal Behaviour & Mental Health, 25(3), 226. https://doi.org/10.1002/cbm.1945
  • Jannini, T. B., Lorenzo, G. D., Bianciardi, E., Niolu, C., Toscano, M., Ciocca, G., Jannini, E.A., & and Siracusano, A. (2022). Off-label uses of selective serotonin reuptake inhibitors (SSRIs). Current Neuropharmacology, 20(4), 693–712. https://doi.org/10.2174/1570159X19666210517150418
  • Jordan, K., Fromberger, P., Stolpmann, G., & Müller, J. L. (2011). The role of testosterone in sexuality and paraphilia—A neurobiological approach. Part I: Testosterone and sexuality. The Journal of Sexual Medicine, 8(11), 2993–3007. https://doi.org/10.1111/j.1743-6109.2011.02394.x
  • Kafka, M. P. (1994). Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders; an open trial. Annals of Clinical Psychiatry, 6(3), 189–195. https://doi.org/10.3109/10401239409149003
  • Kafka, M. P. (2010). Hypersexual disorder: A proposed diagnosis for DSM-V. Archives of Sexual Behavior, 39(2), 377–400. https://doi.org/10.1007/s10508-009-9574-7
  • Kafka, M. P., & Hennen, J. (2000). Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in males with paraphilias and paraphilia-related disorders: A case series. Journal of Clinical Psychiatry, 61(9), 664–670. https://doi.org/10.4088/JCP.v61n0912
  • Kafka, M. P., & Hennen, J. (2003). Hypersexual desire in males: Are males with paraphilias different from males with paraphilia-related disorders? Sexual Abuse: A Journal of Research and Treatment, 15(4), 307–321. https://doi.org/10.1177/107906320301500407
  • Kafka, M. P., & Prentky, R. (1992). A comparative study of nonparaphilic sexual addictions and paraphilias in men. Journal of Clinical Psychiatry, 53(10), 345–350.
  • Kafka, M. P., & Prentky, R. A. (1992). Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. The Journal of Clinical Psychiatry, 53(10), 351–358.
  • Kalichman, S. C., Johnson, J. R., Adair, V., Rompa, D., Multhauf, K., & Kelly, J. A. (1994). Sexual sensation seeking: Scale development and predicting AIDS-risk behavior among homosexually active men. Journal of Personality Assessment, 62(3), 385–397. https://doi.org/10.1207/s15327752jpa6203_1
  • Kaplan, M. S., & Krueger, R. B. (2010). Diagnosis, assessment, and treatment of hypersexuality. Journal of Sex Research, 47(2–3), 181–198. https://doi.org/10.1080/00224491003592863
  • Karila, L., Wéry, A., Weinstein, A., Cottencin, O., Petit, A., Reynaud, M., & Billieux, J. (2014). Sexual addiction or hypersexual disorder: Different terms for the same problem? A review of the literature. Current pharmaceutical design, 20(25), 4012–4020. https://doi.org/10.2174/13816128113199990619
  • Khan, O., Ferriter, M., Huband, N., Powney, M. J., Dennis, J. A., & Duggan, C. (2015). Pharmacological interventions for those who have sexually offended or are at risk of offending. Cochrane Database of Systematic Reviews, (2). https://doi.org/10.1002/14651858.CD007989.pub2
  • Kingston, D. A., & Bradford, J. M. (2013). Hypersexuality and recidivism among sexual offenders. Sexual Addiction & Compulsivity, 20(1–2), 91–105.
  • Klapilová, K., Demidova, L. Y., Elliott, H., Flinton, C. A., Weiss, P., & Fedoroff, J. P. (2019). Psychological treatment of problematic sexual interests: Cross-country comparison. International Review of Psychiatry, 31(2), 169–180. https://doi.org/10.1080/09540261.2019.1591353
  • Koshevaliska, O. (2014). Medical pharmacologic treatment (AKA chemical castration) in the Macedonian criminal code. Balkan Social Science Review, 4(1), 25–45.
  • Kraus, S. W., Krueger, R. B., Briken, P., First, M. B., Stein, D. J., Kaplan, M. S., Voon, V., Abdo, C. H., Grant, J. E., Atalla, E., & and Reed, G. M. (2018). Compulsive sexual behaviour disorder in the ICD‐11. World Psychiatry, 17(1), 109–110. https://doi.org/10.1002/wps.20499
  • Krueger, R. B., & Kaplan, M. S. (2002). Behavioral and psychopharmacological treatment of the paraphilic and hypersexual disorders. Journal of Psychiatric Practice, 8(1), 21–32. https://doi.org/10.1097/00131746-200201000-00004
  • Landgren, V., Malki, K., Bottai, M., Arver, S., & Rahm, C. (2020). Effect of gonadotropin-releasing hormone antagonist on risk of committing child sexual abuse in men with pedophilic disorder: A randomized clinical trial. JAMA Psychiatry, 77(9), 897–905. https://doi.org/10.1001/jamapsychiatry.2020.0440
  • Långström, N., & Hanson, R. K. (2006). High rates of sexual behavior in the general population: Correlates and predictors. Archives of Sexual Behavior, 35(1), 37–52. https://doi.org/10.1007/s10508-006-8993-y
  • Lewis, A., Grubin, D., Ross, C. C., & Das, M. (2017). Gonadotrophin-releasing hormone agonist treatment for sexual offenders: A systematic review. Journal of Psychopharmacology, 31(10), 1281–1293. https://doi.org/10.1177/0269881117714048
  • Lievesley, R., Elliott, H. J., Winder, B., & Norman, C. (2014). Understanding service users’ and therapists’ experiences of pharmacological treatment for sexual preoccupation and/or hypersexuality in incarcerated sex offenders. The Journal of Forensic Psychiatry & Psychology, 25(3), 262–287. https://doi.org/10.1080/14789949.2014.909867
  • Lorrain, D. S., Matuszewich, L., Friedman, R. D., & Hull, E. M. (1997). Extracellular serotonin in the lateral hypothalamic area is increased during the postejaculatory interval and impairs copulation in male rats. The Journal of Neuroscience, 17(23), 9361–9366. https://doi.org/10.1523/JNEUROSCI.17-23-09361.1997
  • Lorrain, D. S., Riolo, J. V., Matuszewich, L., & Hull, E. M. (1999). Lateral hypothalamic serotonin inhibits nucleus accumbens dopamine: Implications for sexual satiety. The Journal of Neuroscience, 19(17), 7648–7652. https://doi.org/10.1523/JNEUROSCI.19-17-07648.1999
  • Lösel, F., & Schmucker, M. (2005). The effectiveness of treatment for sexual offenders: A comprehensive meta-analysis. Journal of Experimental Criminology, 1(1), 117–146. https://doi.org/10.1007/s11292-004-6466-7
  • Maner, J. K., Miller, S. L., Schmidt, N. B., & Eckel, L. A. (2008). Submitting to defeat: Social anxiety, dominance threat, and decrements in testosterone. Psychological Science, 19(8), 764–768. https://doi.org/10.1111/j.1467-9280.2008.02154.x
  • Mann, R. E., Hanson, R. K., & Thornton, D. (2010). Assessing risk for sexual recidivism: Some proposals on the nature of psychologically meaningful risk factors. Sexual Abuse, 22(2), 191–217. https://doi.org/10.1177/1079063210366039
  • Marques, J. K., Wiederanders, M., Day, D. M., Nelson, C., & Van Ommeren, A. (2005). Effects of a relapse prevention program on sexual recidivism: Final results from California’s Sex offender treatment and evaluation project (SOTEP). Sexual Abuse: A Journal of Research and Treatment, 17, 79–107. https://doi.org/10.1177/107906320501700108
  • Marshall, W. L. (2006). Appraising treatment outcome with sexual offenders. In W. L. Marshall, Y. M. Frenandez, L. E. Marshall, & G. A. Serran (Eds.), Sexual Offender Treatment: Controversial Issues (pp. 255–273). John Wiley & Sons Ltd. https://doi.org/10.1002/9780470713457
  • Marshall, L. E., & Marshall, W. L. (2001). Excessive sexual desire disorder among sexual offenders: The development of a research project. Sexual Addiction &compulsivity: The Journal of Treatment and Prevention, 8(3–4), 301–307. https://doi.org/10.1080/107201601753459982
  • Marshall, L. E., Marshall, W. L., Moulden, H. M., & Serran, G. A. (2008). CEU eligible article the prevalence of sexual addiction in incarcerated sexual offenders and matched community nonoffenders. Sexual Addiction & Compulsivity, 15(4), 271–283. https://doi.org/10.1080/10720160802516328
  • Marshall, L. E., O’Brien, M. D., & Kingston, D. A. (2009). Problematic hypersexual behavior in incarcerated sexual offenders and a socioeconomically matched community comparison group. 28th Annual Research and Treatment Conference for the Association for the Treatment of Sexual Abusers, USA, Dallas.
  • McAlinden, A. M. (2012). The governance of sexual offending across Europe: Penal policies, political economies and the institutionalization of risk. Punishment & Society, 14(2), 166–192. https://doi.org/10.1177/1462474511435573
  • McBride, K. R., Reece, M., & Sanders, S. A. (2008). Using the sexual compulsivity scale to predict outcomes of sexual behavior in young adults. Sexual Addiction & Compulsivity, 15(2), 97–115. https://doi.org/10.1080/10720160802035816
  • McGrath, R. J., Cumming, G. F., Burchard, B. L., Zeoli, S., & Ellerby, L. (2010). Current practices and emerging trends in sexual abuser management: The Safer Society 2009 North American survey. Safer Society Press.
  • Mews, A., DiBella, L., & Purver, M. (2017). Impact evaluation of the prison-based core sex offender treatment programme. Ministry of Justice.
  • Montejo, A. L., Llorca, G., Izquierdo, J. A., & Rico-Villademoros, F. (2001). Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. Spanish working group for the study of psychotropic-related sexual dysfunction. The Journal of Clinical Psychiatry, 62 Suppl 3(3), 10–21.
  • Moret, C., Isaac, M., & Briley, M. (2009). Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors. Journal of Psychopharmacology, 23(8), 967–974. https://doi.org/10.1177/0269881108093582
  • Murphy, L., & Fedoroff, J. P. (2017). Assessing people with problematic sexual interests: An overview of the Royal’s sexual behaviours clinic and assessment laboratory. Russian Journal of Psychiatry, 5, 73–79.
  • National Offender Management Service. (2015). Working with Offenders with Personality Disorder. A Practitioners Guide. https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/10/work-offndrs-persnlty-disorder-oct15.pdf
  • NICE. (2015). Hypersexuality: fluoxetine. Evidence summary. https://www.nice.org.uk/advice/esuom46/chapter/full-evidence-summary#introduction-and-current-guidance-2
  • Öberg, K. G., Hallberg, J., Kaldo, V., Dhejne, C., & Arver, S. (2017). Hypersexual disorder according to the hypersexual disorder screening inventory in help-seeking Swedish men and women with self-identified hypersexual behavior. Sexual Medicine, 5(4), 229–236. https://doi.org/10.1016/j.esxm.2017.08.001
  • Odlaug, B. L., Lust, K., Schreiber, L. R., Christenson, G., Derbyshire, K., Harvanko, A., Golden, D., & and Grant, J. E. (2013). Compulsive sexual behavior in young adults. Annals of Clinical Psychiatry, 25(3), 193–200.
  • Opitz, D. M., Tsytsarev, S. V., & Froh, J. (2009). Women’s sexual addiction and family dynamics, depression and substance abuse. Sexual Addiction & Compulsivity, 16(4), 324–340. https://doi.org/10.1080/10720160903375749
  • Parker, G., Roy, K., Menkes, D. B., Snowdon, J., Boyce, P., Grounds, D. … Stringer, C. (2000). How long does it take for antidepressant therapies to act? Australian & New Zealand Journal of Psychiatry, 34(1), 65–70. https://doi.org/10.1046/j.1440-1614.2000.00684.x
  • Parsons, J. T., Grov, C., & Golub, S. A. (2012). Sexual compulsivity, co-occurring psychosocial health problems, and HIV risk among gay and bisexual men: Further evidence of a syndemic. American Journal of Public Health, 102(1), 156–162. https://doi.org/10.2105/AJPH.2011.300284
  • Paunović, N., & Hallberg, J. (2014). Conceptualization of hypersexual disorder with the behavioural-cognitive inhibition theory. Psychology, 05(2), 151. https://doi.org/10.4236/psych.2014.52024
  • Perry, M., Accordino, M. P., & Hewes, R. L. (2007). An investigation of Internet use, sexual and nonsexual sensation seeking, and sexual compulsivity among college students. Sexual Addiction & Compulsivity, 14(4), 321–335. https://doi.org/10.1080/10720160701719304
  • Prenzler, T., McKillop, N., Rayment McHugh, S., & Christensen, L. (2023). Best practice in sexual offender rehabilitation and reintegration programs. Journal of Criminological Research, Policy and Practice, 9(3/4), 207–221. https://doi.org/10.1108/JCRPP-07-2023-0036
  • Reid, R. C. (2007). Assessing readiness to change among clients seeking help for hypersexual behavior. Sexual Addiction & Compulsivity, 14(3), 167–186. https://doi.org/10.1080/10720160701480204
  • Reid, R. C., Bramen, J. E., Anderson, A., & Cohen, M. S. (2014). Mindfulness, emotional dysregulation, impulsivity, and stress proneness among hypersexual patients. Journal of Clinical Psychology, 70(4), 313–321. https://doi.org/10.1002/jclp.22027
  • Reid, R. C., Carpenter, B. N., & Lloyd, T. Q. (2009). Assessing psychological symptom patterns of patients seeking help for hypersexual behavior. Sexual and Relationship Therapy, 24(1), 47–63. https://doi.org/10.1080/14681990802702141
  • Reid, R. C., Carpenter, B. N., Spackman, M., & Willes, D. L. (2008). Alexithymia, emotional instability and vulnerability to stress proneness in patients seeking help for hypersexual behavior. Journal of Sex & Marital Therapy, 34(2), 133–149.
  • Reid, R. C., Garos, S., & Fong, T. (2012). Psychometric development of the hypersexual behavior consequences scale. Journal of Behavioral Addictions, 1(3), 115–122. https://doi.org/10.1556/jba.1.2012.001
  • Rocha, I. C. O., & Valença, A. M. (2023). The efficacy of CBT based interventions to sexual offenders: A systematic review of the last decade literature. International Journal of Law and Psychiatry, 87, 101856. https://doi.org/10.1016/j.ijlp.2022.101856
  • Rooney, B. M., Tulloch, T. G., & Blashill, A. J. (2018). Psychosocial syndemic correlates of sexual compulsivity among men who have sex with men: A meta-analysis. Archives of Sexual Behavior, 47(1), 75–93. https://doi.org/10.1007/s10508-017-1032-3
  • Ryan, T. J., Huss, M. T., & Scalora, M. J. (2017). Differentiating sexual offender type on measures of impulsivity and compulsivity. Sexual Addiction & Compulsivity, 24(1–2), 108–125. https://doi.org/10.1080/10720162.2016.1189863
  • Sauter, J., Turner, D., Briken, P., & Rettenberger, M. (2020). Testosterone-lowering medication and its association with recidivism risk in individuals convicted of sexual offenses. Sexual Abuse, 1–26. https://doi.org/10.1177/1079063220910723
  • Sauter, J., Turner, D., Briken, P., & Rettenberger, M. (2021). Testosterone-lowering medication and its association with recidivism risk in individuals convicted of sexual offenses. Sexual Abuse, 33(4), 475–500. https://doi.org/10.1177/1079063220910723
  • Schmucker, M., & Lösel, F. (2015). The effects of sexual offender treatment on recidivism: An international meta-analysis of sound quality evaluations. Journal of Experimental Criminology, 11(4), 597–630. https://doi.org/10.1007/s11292-015-9241-z
  • Schmucker, M., & Lösel, F. (2017). Sexual offender treatment for reducing recidivism among convicted sex offenders: A systematic review and meta‐analysis. Campbell Systematic Reviews, 13(1), 1–75. https://doi.org/10.4073/csr.2017.8
  • Seto, M. C. (2019). The motivation-facilitation model of sexual offending. Sexual Abuse, 31(1), 3–24. https://doi.org/10.1177/1079063217720919
  • Seto, M. C., Augustyn, C., Roche, K., & Hilkes, G. (2023). Empirically-based dynamic risk and protective factors for sexual offending. Clinical Psychology Review, 106, 102355. https://doi.org/10.1016/j.cpr.2023.102355
  • Sutton, K. S., Stratton, N., Pytyck, J., Kolla, N. J., & Cantor, J. M. (2015). Patient characteristics by type of hypersexuality referral: A quantitative chart review of 115 consecutive male cases. Journal of Sex & Marital Therapy, 41(6), 563–580. https://doi.org/10.1080/0092623X.2014.935539
  • Thibaut, F., Barra, F. D. L., Gordon, H., Cosyns, P., Bradford, J. M., & WFSBP Task Force on Sexual Disorders. (2010). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of paraphilias. The World Journal of Biological Psychiatry, 11(4), 604–655.
  • Thibaut, F., Cosyns, P., Fedoroff, J. P., Briken, P., Goethals, K., Bradford, J. M., & WFSBP Task Force on Paraphilias. (2020). The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders. The World Journal of Biological Psychiatry, 21(6), 412–490. https://doi.org/10.1080/15622975.2020.1744723
  • Thompson, D., & Brown, H. (1997). Men with intellectual disabilities who sexually abuse: A review of the literature. Journal of Applied Research in Intellectual Disabilities, 10(2), 140–158. https://doi.org/10.1111/j.1468-3148.1997.tb00014.x
  • Thompson, W. M., Dabbs, J. M., Jr., & Frady, R. L. (1990). Changes in saliva testosterone levels during a 90-day shock incarceration program. Criminal Justice and Behavior, 17(2), 246–252. https://doi.org/10.1177/0093854890017002007
  • Thornton, D. (2002). Constructing and testing a framework for dynamic risk assessment. Sexual Abuse: A Journal of Research and Treatment, 14(2), 139–153. https://doi.org/10.1177/107906320201400205
  • Thornton, D., Mann, R., Webster, S., Blud, L., Travers, R., Friendship, C., & Erikson, M. (2003). Distinguishing and combining risks for sexual and violent recidivism. Annals of the New York Academy of Sciences, 989(1), 225–235. https://doi.org/10.1111/j.1749-6632.2003.tb07308.x
  • Turner, D., & Briken, P. (2018). Treatment of paraphilic disorders in sexual offenders or men with a risk of sexual offending with luteinizing hormone-releasing hormone agonists: An updated systematic review. The Journal of Sexual Medicine, 15(1), 77–93. https://doi.org/10.1016/j.jsxm.2017.11.013
  • Turner, D., & Briken, P. (2021). Pharmacological treatments for individuals with paraphilic disorders or at risk for sexual offending. In L. A. Craig (Ed.), Sexual deviance (pp. 282–294). John Wiley & Sons, Inc. https://doi.org/10.1002/9781119771401.ch18.
  • Turner, D., Petermann, J., Harrison, K., Krueger, R., & Briken, P. (2017). Pharmacological treatment of patients with paraphilic disorders and risk of sexual offending: An international perspective. The World Journal of Biological Psychiatry, 20(8), 616–625. https://doi.org/10.1080/15622975.2017.1395069
  • Ullman, S. E., Relyea, M., Peter-Hagene, L., & Vasquez, A. L. (2013). Trauma histories, substance use coping, PTSD, and problem substance use among sexual assault victims. Addictive Behaviors, 38(6), 2219–2223. https://doi.org/10.1016/j.addbeh.2013.01.027
  • von Franqué, F., Klein, V., & Briken, P. (2015). Which techniques are used in psychotherapeutic interventions for nonparaphilic hypersexual behavior? Sexual Medicine Reviews, 3(1), 3–10. https://doi.org/10.1002/smrj.34
  • Wainberg, M. L., Muench, F., Morgenstern, J., Hollander, E., Irwin, T. W., Parsons, J. T., & O’Leary, A. (2006). A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. The Journal of Clinical Psychiatry, 67(12), 1968–1973. https://doi.org/10.4088/JCP.v67n1218
  • Walton, M. T., Cantor, J. M., & Lykins, A. D. (2017). An online assessment of personality, psychological, and sexuality trait variables associated with self-reported hypersexual behavior. Archives of Sexual Behavior, 46(3), 721–733. https://doi.org/10.1007/s10508-015-0606-1
  • Ward, T., & Beech, A. R. (2017). The integrated theory of sexual offending-revised: A multifield perspective. In A. R. Beech & T. Ward (Eds.), The Wiley handbook on the theories, assessment and treatment of sexual offending. Wiley-Blackwell. https://doi.org/10.1002/9781118574003.wattso006.
  • Wechsler, D. (2008). Wechsler adult intelligence scale–fourth edition. Pearson.
  • Wechsler, D. (2011). Wechsler abbreviated scale of intelligence–second edition manual. Pearson.
  • Weiss, P. (2017). Poruchy sexuální preference. Galén.
  • Winder, B., Fedoroff, J. P., Grubin, D., Klapilová, K., Kamenskov, M., Tucker, D., Basinskaya, I.A., & Vvedensky, G. E. (2019). The pharmacologic treatment of problematic sexual interests, paraphilic disorders, and sexual preoccupation in adult men who have committed a sexual offence. International Review of Psychiatry, 31(2), 159–168. https://doi.org/10.1080/09540261.2019.1577223
  • Winder, B., Lievesley, R., Elliott, H., Hocken, K., Faulkner, J., Norman, C., & Kaul, A. (2018). Evaluation of the use of pharmacological treatment with prisoners experiencing high levels of hypersexual disorder. The Journal of Forensic Psychiatry & Psychology, 29(1), 53–71. https://doi.org/10.1080/14789949.2017.1337801
  • Winder, B., Lievesley, R., Elliott, H. J., Norman, C., & Kaul, A. (2014). Understanding the journeys of high‐risk male sex offenders voluntarily receiving medication to reduce their sexual preoccupation and/or hypersexuality. In D. T. Wilcox, T. Garrett, & L. Harkin (Eds.), Sex offender treatment: A case study approach to issues and interventions (pp. 342–370). Wiley & Sons Ltd. https://doi.org/10.1002/9781118674352.ch19.
  • Winder, B., Lievesley, R., Kaul, A., Elliott, H. J., Thorne, K., & Hocken, K. (2014). Preliminary evaluation of the use of pharmacological treatment with convicted sexual offenders experiencing high levels of sexual preoccupation, hypersexuality and/or sexual compulsivity. The Journal of Forensic Psychiatry & Psychology, 25(2), 176–194. https://doi.org/10.1080/14789949.2014.903504
  • Wooden, W. S., & Parker, J. (1982). Men Behind Bars: Sexual Exploitation in Prisons. Da Capo Press.
  • Worley, V. B., & Worley, R. M. (2021). Inmate public autoerotism and hostile work environments: An examination of federal cases. Journal of Crime and Justice, 44(2), 180–194. https://doi.org/10.1080/0735648X.2020.1795902
  • Yoon, I. S., Houang, S. T., Hirshfield, S., & Downing, M. J. (2016). Compulsive sexual behavior and HIV/STI risk: A review of current literature. Current Addiction Reports, 3(4), 387–399. https://doi.org/10.1007/s40429-016-0121-z
  • Zimmer, F., & Imhoff, R. (2020). Abstinence from masturbation and hypersexuality. Archives of Sexual Behavior, 49(4), 1333–1343. https://doi.org/10.1007/s10508-019-01623-8